We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$778M
AUM Growth
-$1.85M
Cap. Flow
-$35.3M
Cap. Flow %
-4.54%
Top 10 Hldgs %
34.42%
Holding
5,522
New
920
Increased
1,531
Reduced
1,579
Closed
1,330

Sector Composition

Rank Sector Weight
1 Industrials 6%
2 Financials 5.45%
3 Technology 5.24%
4 Consumer Discretionary 4.75%
5 Healthcare 3.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFZ
2326
DELISTED
BARRY (R.G.) CORPORATION
DFZ
$11K ﹤0.01%
580
-182
-24% -$3.43K
VITC
2327
DELISTED
VITACOST COM INC COM STK (DE)
VITC
$11K ﹤0.01%
1,728
+759
+78% +$4.93K
HITT
2328
DELISTED
HITTITE MICROWAVE CORP
HITT
$11K ﹤0.01%
138
-29
-17% -$1.87K
TDN
2329
DELISTED
DEUTSCHE X-TRACKERS 2030 TARGET DATE ETF
TDN
$11K ﹤0.01%
401
+201
+101% +$5.71K
ABUS icon
2330
Arbutus Biopharma
ABUS
$913M
$10K ﹤0.01%
737
-95
-11% -$1.35K
GOLD
2331
Gold.com Inc
GOLD
$1.26B
$10K ﹤0.01%
+1,864
New +$10.9K
ARCO icon
2332
Arcos Dorados Holdings
ARCO
$1.78B
$10K ﹤0.01%
929
+29
+3% +$273
AVA icon
2333
Avista
AVA
$3.25B
$10K ﹤0.01%
301
-70
-19% -$2.22K
AVDL
2334
DELISTED
Avadel Pharmaceuticals
AVDL
$10K ﹤0.01%
637
+537
+537% +$6.48K
BXC icon
2335
BlueLinx
BXC
$565M
$10K ﹤0.01%
705
-1,561
-69% -$20.2K
BBBY
2336
Bed Bath & Beyond
BBBY
$440M
$10K ﹤0.01%
889
-2,159
-71% -$26.5K
CBU icon
2337
Community Bank
CBU
$3.48B
$10K ﹤0.01%
+268
New +$9.89K
CG icon
2338
Carlyle Group
CG
$17.9B
$10K ﹤0.01%
293
+230
+365% +$7.57K
CLM icon
2339
Cornerstone Strategic Value Fund
CLM
$2.23B
$10K ﹤0.01%
420
+339
+419% +$8.37K
COHU icon
2340
Cohu
COHU
$2.45B
$10K ﹤0.01%
914
+314
+52% +$3.31K
COP icon
2341
ConocoPhillips
COP
$140B
$10K ﹤0.01%
121
-3,042
-96% -$237K
CSM icon
2342
ProShares Large Cap Core Plus
CSM
$532M
$10K ﹤0.01%
400
CSTE icon
2343
Caesarstone
CSTE
$80.2M
$10K ﹤0.01%
195
+125
+179% +$6.36K
BGMS
2344
Bio Green Med Solution Inc
BGMS
$5.74M
0
DARE icon
2345
Dare Bioscience
DARE
$20.1M
$10K ﹤0.01%
+14
New +$10.8K
EMO
2346
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.01B
$10K ﹤0.01%
77
+33
+75% +$3.93K
EOT
2347
Eaton Vance National Municipal Opportunities Trust
EOT
$272M
$10K ﹤0.01%
500
ETO
2348
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
ETO
$516M
$10K ﹤0.01%
400
EYPT icon
2349
EyePoint Inc
EYPT
$1.03B
$10K ﹤0.01%
228
+136
+148% +$5.13K
FCEL icon
2350
FuelCell Energy
FCEL
$1.69B
$10K ﹤0.01%
1

Similar funds

Tower Research Capital (TRC)'s Q2 2014 Portfolio in Review

As of Q2 2014, Tower Research Capital (TRC) held 5,522 positions worth $778M, down 0.24% from $780M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $35.3M in Q2 2014, closing 1,330 positions and reducing 1,579 holdings. Its most notable exit was iShares Core S&P Small-Cap ETF, an estimated $10.7M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 6% of assets, up from 5.1% a quarter earlier, followed by Financials and Technology.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $9.03M.

  • Tower Research Capital (TRC)'s largest Q2 2014 buy was iShares Russell 1000 Value ETF: 89,185 shares worth $9.03M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2014, an estimated $177M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2014 reduction was Invesco QQQ Trust, cutting an estimated $110M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Small-Cap ETF in Q2 2014, selling an estimated $10.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $778M portfolio in Q2 2014.
  • Tower Research Capital (TRC) opened 920 new positions and closed 1,330 in Q2 2014.
  • Tower Research Capital (TRC)'s portfolio value fell 0.24% quarter-over-quarter to $778M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2014, filed 14 Aug 2014.